• Home
  • Search Results

Search Results

2796 studies match your search
Coming Soon

Get Real and Heel: Cancer and Exercise Registry Study

Exercise has been shown to be beneficial for the management of common adverse effects of cancer and its treatment such as fatigue, anxiety, depression, changes in strength and physical function, and sleep disruption. Get Real and Heel provides participants with the opportunity to obtain these benefits, regardless of cancer type and disease stage, and without cost.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Brain and Other Nervous System, Breast, and 19 more)
  • Wellness and Lifestyle
  • Movement
Open

Brain research on decision-making

Do your emotions and moods change quickly? Are you shy? If you answered "yes" to any one of those questions, you may be eligible to participate in a paid study on decision-making and brain development.

Age & Gender
  • 18 years ~ 25 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Brain, Head, Nervous System
  • Developmental
  • Mental and Emotional Health
Open

Preventing Injured Knees from osteoArthritis

Have you recently had an anterior cruciate ligament injury and will be undergoing anterior cruciate ligament reconstruction surgery? If so, you may be able to participate in a study comparing the effects on pain relief and arthritis prevention of metformin or placebo. Compensation provided.

Age & Gender
  • 18 years ~ 45 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Pain
  • Wellness and Lifestyle
  • Surgery and post-operative healing
Open

Immunotherapy study for patients with stage II-III breast cancer

Do you have Stage II or III Breast cancer? If you have enough tissue from your breast cancer diagnosis to send for Mammaprint genomic testing, you may be able to take part in this research study. In this study, we want to learn more about adding an immunotherapy drug, durvalumab, to your chemotherapy treatment. The Mammaprint testing is conducted at no cost to you and the cost of durvalumab is covered.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Breast)
Coming Soon

Adults with Blood Cancer

To find out if the study drug AZD9829 is safe and tolerable and effective in treating blood cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Coming Soon

Randomized Phase III Trial of mFOLFIRINOX vs. FOLFOX With Nivolumab

This study is being done to answer the following question: Can we extend your life after the diagnosis of your cancer in the stomach, esophagus, or gastroesophageal junction by adding a third chemotherapy drug to the usual combination of two chemotherapy drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for treatment of your cancer in the stomach, esophagus, or gastroesophageal junction. The usual approach is defined as care most people get for cancer in the stomach, esophagus, or gastroesophageal junction.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Stomach and Esophageal)
Open

AYA Connect

Are you a young adult cancer survivor who would like to lose weight? Interested in using technology to support a healthy diet, get more physically active, and improve your mental health? Researchers at the University of North Carolina at Chapel Hill are looking for volunteers to sign up for a 6-month research program that will involve using a Fitbit activity tracker, digital smart scale, and mobile app. For more information and to see if you qualify, visit our study website at www.uncweightresearch.org

Age & Gender
  • 18 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Eating, Nutrition, and Metabolism
  • Obesity
  • Wellness and Lifestyle
  • Movement
Visit Location
100% Remote (online, phone, text)
Open

Individualizing Treatment for Asthma in Primary Care

The iTREAT study will compare different ways of treating asthma: a pill or adding a second inhaler to see if they reduce the need for emergency care or going to the hospital.

Age & Gender
  • 13 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Lungs and Breathing
Open

HPV vaccination perception among rural NC parents

Do you have a child ages 9-12? Do you live in rural North Carolina? You may be able to participate in a research study that is exploring how parents, particularly in rural areas, want to have conversations about HPV vaccination with their children's' doctors and nurses. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Minority Health
  • Opinions and Perceptions
  • Parents of Children
Visit Location
100% Remote (online, phone, text)
Coming Soon

Advanced Melanoma Tumor Study

This is a study to test the dosing and safety of the drug AB248 for people who have an advanced melanoma tumors and who have previously received systemic therapy.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research